Drugs

Drugs

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

We continue to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year's live-online...
Cancer Journey:
Cancer Type:
We continue to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year's live-online...
Cancer Journey:
Cancer Type:
We continue to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year's live-online...
Cancer Journey:
Cancer Type:
For this series of case based panel discussions, Dr. Benjamin Levy is joined by Dr. Stephen Liu and Dr. Julie Brahmer to discuss treatment for...
Cancer Journey:
Cancer Type:
For this series of Case Based Panel Discussions, Dr. Benjamin Levy is joined by Dr. Stephen Liu and Dr. Julie Brahmer to discuss treatment for...
Cancer Journey:
Cancer Type:

Articles

GRACE is excited to share with you a partnership with Lilly Oncology to provide you information that reflects our shared interests. We are happy to...
Cancer Type:
Register Now for the Targeted Therapies Patient Forum Join our faculty April 6, 2019, in Philadelphia, PA to learn about the newest breakthroughs in...
Cancer Type:
The FDA just approved a new therapy for the approximately 4% of patients with NSCLC who have the molecular marker known as an ALK rearrangement. The...
Cancer Journey:
Cancer Type:
Probably the most immediate potentially practice-changing presentation from ASCO was the Japanese J-ALEX study in the subset of about 4-5% of...
Cancer Journey:
Cancer Type:
Fast forward 1.5 years, and we now have the early results of LUX-Lung-7, and they show that these EGFR TKIs are not completely interchangeable...
Cancer Journey:
Cancer Type:

Community Forum

The Targeted Therapies Patient Forum from CancerGrace.org is finally here and FREE to anyone. Originally scheduled for earlier this year our forum is...
Cancer Journey:
Cancer Type:
MARCH 28, PUT IN ON YOUR CALENDARS. I always learn so much at the live patient forums even attending them virtually. Our faculty is outstanding in...
Cancer Journey:
Cancer Type:
Greetings all, I'm a medical doctor from Vietnam. I want to discuss to you about my patient. He is 58 years old, he is hospitalize with chronic...
Cancer Journey:
Cancer Type:
Progression after 3 1/2 years on Tarceva. Tissue biopsy showed T790m negative. Any suggestions/experience on next steps? Onc suggesting I move to Afatinib or a Opdivo. PDL1 was tested and is <1%.
Cancer Journey:
Cancer Type: